The board appointed Agrawal as the CEO and designated him as key managerial personnel (KMP) of the company.

Agrawal is a qualified Chartered Accountant with nearly 22 years of experience. He has worked extensively on M&A, partnering with investment bankers across Japan, Europe, UK and US and is a highly regarded banker in the India-Japan corridor. He was managing director and head of the investment banking business at Edelweiss.

Anupam Rasayan India is one of the leading companies engaged in the custom synthesis (CSM) and manufacturing of specialty chemicals in India. Its business verticals are life science related specialty chemicals comprising products related to agrochemicals, personal care and pharmaceuticals, and other specialty chemicals, comprising specialty pigment and dyes, and polymer additives.

The company's consolidated net profit declined 2.7% to Rs 38.60 crore despite of 12.4% rise in net sales to Rs 386.39 crore in Q1 FY24 over Q1 FY23.

Shares of Anupam Rasayan India declined 0.58% to Rs 995 on the BSE.